HomepageKVUE • NYSE
add
Kenvue Inc
Vorige slotkoers
$ 21,10
Dag-range
$ 20,68 - $ 20,97
Jaar-range
$ 17,67 - $ 24,46
Beurswaarde
39,97 mld. USD
Gem. volume
11,85 mln.
Koers/winst
37,65
Dividendrendement
3,93%
Primaire beurs
NYSE
Marktnieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
(USD) | sep 2024info | Wijziging j-o-j |
---|---|---|
Opbrengst | 3,90 mld. | -0,41% |
Bedrijfskosten | 1,60 mld. | 3,90% |
Netto inkomsten | 383,00 mln. | -12,56% |
Netto winstmarge | 9,82 | -12,24% |
Winst per aandeel | 0,28 | -9,68% |
EBITDA | 871,00 mln. | 0,58% |
Effectief belastingtarief | 33,62% | — |
Balans
Totale activa
Totale passiva
(USD) | sep 2024info | Wijziging j-o-j |
---|---|---|
Contanten en kortetermijnbeleggingen | 1,06 mld. | -0,47% |
Totale activa | 26,92 mld. | -0,56% |
Totale passiva | 16,28 mld. | 0,60% |
Totaal aandelenvermogen | 10,64 mld. | — |
Uitstaande aandelen | 1,92 mld. | — |
Koers-boekwaardeverhouding | 3,80 | — |
Rendement op activa | 6,45% | — |
Rendement op kapitaal | 9,01% | — |
Kasstroom
Nettomutatie in liquide middelen
(USD) | sep 2024info | Wijziging j-o-j |
---|---|---|
Netto inkomsten | 383,00 mln. | -12,56% |
Operationele kasstroom | 249,00 mln. | -63,06% |
Kasstroom uit beleggingen | -56,00 mln. | 46,67% |
Kasstroom uit financiering | -162,00 mln. | 77,69% |
Nettomutatie in liquide middelen | 43,00 mln. | 125,44% |
Vrije kasstroom | 315,12 mln. | -53,16% |
Over
Kenvue Inc. is an American consumer health company. Formerly the Consumer Healthcare division of Johnson & Johnson, Kenvue is the proprietor of well-known brands such as Aveeno, Band-Aid, Benadryl, Combantrin, Zyrtec, Johnson's, Listerine, Mylanta, Neutrogena, Trosyd, Calpol, Tylenol, and Visine.
Kenvue is incorporated under the Delaware General Corporation Law and is headquartered in the Skillman section of Montgomery Township, New Jersey, with plans to relocate its global headquarters to Summit, New Jersey. Before the spin-off, Johnson & Johnson's consumer health division was based in Skillman, even as its pharmaceutical division and medical technologies division, as well as the overall company headquarters, were located in nearby New Brunswick, New Jersey. Wikipedia
Opgericht
23 feb 2022
Hoofdvestiging
Website
Werknemers
22.000